---
figid: PMC6479272__gr13
figlink: /pmc/articles/PMC6479272/figure/f0065/
number: Fig. 13
caption: A partly hypothetical model describing the characteristic shifts of balance
  within the sphingomyelin/salvage pathway attributed to immune low and immune high
  tumor subtypes/subgroups of patients. The scheme shows the interconnected network
  of the sphingolipid mediators and the corresponding sphingolipid-modifying enzymes;
  those genes that are upregulated in either subgroup () are highlighted in red. Furthermore
  shown is a schematic illustration of cellular interplay at the tumor site. The model
  consolidates cumulative data from the correlation analysis and unsupervised hierarchical
  clustering for sphingolipid/lysophosphatidate/immune-associated genes, clustering-based
  patient stratification and comparative analysis of gene expression data sets, expression
  profiles of genes composing the sphingolipid/lysophosphatidate/immune-associated
  signature in ovarian cancer cell lines, and integrative analysis of the expression
  patterns across transcriptomic data sets. SPC, sphingosylphosphorylcholine; LPC,
  lysophosphatidylcholine. (For interpretation of the references to color in this
  figure legend, the reader is referred to the web version of this article.)
pmcid: PMC6479272
papertitle: Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune
  System in Ovarian Cancer.
reftext: Anastasia Meshcheryakova, et al. Comput Struct Biotechnol J. 2019;17:537-560.
pmc_ranked_result_index: '65677'
pathway_score: 0.8745274
filename: gr13.jpg
figtitle: Partly hypothetical model describing the characteristic shifts of balance
  within the sphingomyelin/salvage pathway attributed to immune low and immune high
  tumor subtypes/subgroups of patients
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6479272__gr13.html
  '@type': Dataset
  description: A partly hypothetical model describing the characteristic shifts of
    balance within the sphingomyelin/salvage pathway attributed to immune low and
    immune high tumor subtypes/subgroups of patients. The scheme shows the interconnected
    network of the sphingolipid mediators and the corresponding sphingolipid-modifying
    enzymes; those genes that are upregulated in either subgroup () are highlighted
    in red. Furthermore shown is a schematic illustration of cellular interplay at
    the tumor site. The model consolidates cumulative data from the correlation analysis
    and unsupervised hierarchical clustering for sphingolipid/lysophosphatidate/immune-associated
    genes, clustering-based patient stratification and comparative analysis of gene
    expression data sets, expression profiles of genes composing the sphingolipid/lysophosphatidate/immune-associated
    signature in ovarian cancer cell lines, and integrative analysis of the expression
    patterns across transcriptomic data sets. SPC, sphingosylphosphorylcholine; LPC,
    lysophosphatidylcholine. (For interpretation of the references to color in this
    figure legend, the reader is referred to the web version of this article.)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CERS3
  - ASAH1
  - CERS1
  - CERS2
  - LPAR3
  - LPAR6
  - PCSK7
  - MAG
  - CERS4
  - CERS5
  - CERS6
  - CD14
  - CD163
  - CD68
  - CERK
  - LPAR1
  - LPAR2
  - SGPP1
  - SGPP2
  - SMPD1
  - SMPD3
  - NAAA
  - PLPP1
  - PLPP3
  - CD1A
  - PLPP2
  - ENPP2
  - LPA
  - LPAR5
  - SGMS1
  - SGMS2
  - SFTPC
  - SPHK1
  - SPHK2
  - SMPD2
  - MBTPS1
  - S1PR1
  - TCEA1
  - sphingomyelin
  - LPC
  - ceramide
  - LPA
  - sphingosine
  - CIP
  - tumor
genes:
- word: CERS1-6
  symbol: CERS3
  source: hgnc_symbol
  hgnc_symbol: CERS3
  entrez: '204219'
- word: ASAH1
  symbol: ASAH1
  source: hgnc_symbol
  hgnc_symbol: ASAH1
  entrez: '427'
- word: CERS1-6
  symbol: CERS1
  source: hgnc_symbol
  hgnc_symbol: CERS1
  entrez: '10715'
- word: CERS1-6
  symbol: CERS2
  source: hgnc_symbol
  hgnc_symbol: CERS2
  entrez: '29956'
- word: LPAR1,2,3,5,6
  symbol: LPAR3
  source: hgnc_symbol
  hgnc_symbol: LPAR3
  entrez: '23566'
- word: LPAR1,2,3,5,6
  symbol: LPAR6
  source: hgnc_symbol
  hgnc_symbol: LPAR6
  entrez: '10161'
- word: LPC
  symbol: LPC
  source: hgnc_alias_symbol
  hgnc_symbol: PCSK7
  entrez: '9159'
- word: MAG
  symbol: MAG
  source: hgnc_symbol
  hgnc_symbol: MAG
  entrez: '4099'
- word: CERS1-6
  symbol: CERS4
  source: hgnc_symbol
  hgnc_symbol: CERS4
  entrez: '79603'
- word: CERS1-6
  symbol: CERS5
  source: hgnc_symbol
  hgnc_symbol: CERS5
  entrez: '91012'
- word: CERS1-6
  symbol: CERS6
  source: hgnc_symbol
  hgnc_symbol: CERS6
  entrez: '253782'
- word: CD14
  symbol: CD14
  source: hgnc_symbol
  hgnc_symbol: CD14
  entrez: '929'
- word: CD163
  symbol: CD163
  source: hgnc_symbol
  hgnc_symbol: CD163
  entrez: '9332'
- word: CD68
  symbol: CD68
  source: hgnc_symbol
  hgnc_symbol: CD68
  entrez: '968'
- word: CERK
  symbol: CERK
  source: hgnc_symbol
  hgnc_symbol: CERK
  entrez: '64781'
- word: LPAR1,2,3,5,6
  symbol: LPAR1
  source: hgnc_symbol
  hgnc_symbol: LPAR1
  entrez: '1902'
- word: LPAR1,2,3,5,6
  symbol: LPAR2
  source: hgnc_symbol
  hgnc_symbol: LPAR2
  entrez: '9170'
- word: SGPP1/2
  symbol: SGPP1
  source: hgnc_symbol
  hgnc_symbol: SGPP1
  entrez: '81537'
- word: SGPP1/2
  symbol: SGPP2
  source: hgnc_symbol
  hgnc_symbol: SGPP2
  entrez: '130367'
- word: SMPD1
  symbol: SMPD1
  source: hgnc_symbol
  hgnc_symbol: SMPD1
  entrez: '6609'
- word: SMPD1/3
  symbol: SMPD3
  source: hgnc_symbol
  hgnc_symbol: SMPD3
  entrez: '55512'
- word: NAAA
  symbol: NAAA
  source: hgnc_symbol
  hgnc_symbol: NAAA
  entrez: '27163'
- word: PPAP2A
  symbol: PPAP2A
  source: hgnc_prev_symbol
  hgnc_symbol: PLPP1
  entrez: '8611'
- word: PPAP2A/B
  symbol: PPAP2B
  source: hgnc_prev_symbol
  hgnc_symbol: PLPP3
  entrez: '8613'
- word: CD1
  symbol: CD1
  source: hgnc_prev_symbol
  hgnc_symbol: CD1A
  entrez: '909'
- word: PPAP2C
  symbol: PPAP2C
  source: hgnc_prev_symbol
  hgnc_symbol: PLPP2
  entrez: '8612'
- word: ENPP2
  symbol: ENPP2
  source: hgnc_symbol
  hgnc_symbol: ENPP2
  entrez: '5168'
- word: LPA
  symbol: LPA
  source: hgnc_symbol
  hgnc_symbol: LPA
  entrez: '4018'
- word: LPAR1,2,3,5,6
  symbol: LPAR5
  source: hgnc_symbol
  hgnc_symbol: LPAR5
  entrez: '57121'
- word: SGMS1
  symbol: SGMS1
  source: hgnc_symbol
  hgnc_symbol: SGMS1
  entrez: '259230'
- word: SGMS2
  symbol: SGMS2
  source: hgnc_symbol
  hgnc_symbol: SGMS2
  entrez: '166929'
- word: SPC
  symbol: SP-C
  source: hgnc_alias_symbol
  hgnc_symbol: SFTPC
  entrez: '6440'
- word: SPHK1
  symbol: SPHK1
  source: hgnc_symbol
  hgnc_symbol: SPHK1
  entrez: '8877'
- word: SPHK1/2
  symbol: SPHK2
  source: hgnc_symbol
  hgnc_symbol: SPHK2
  entrez: '56848'
- word: SMPD2
  symbol: SMPD2
  source: hgnc_symbol
  hgnc_symbol: SMPD2
  entrez: '6610'
- word: S1P
  symbol: S1P
  source: hgnc_alias_symbol
  hgnc_symbol: MBTPS1
  entrez: '8720'
- word: S1PR1,2,3,5
  symbol: S1PR1
  source: hgnc_symbol
  hgnc_symbol: S1PR1
  entrez: '1901'
- word: S1PR1,2,3,5
  symbol: SII
  source: hgnc_alias_symbol
  hgnc_symbol: TCEA1
  entrez: '6917'
chemicals:
- word: sphingomyelin
  source: MESH
  identifier: D013109
- word: LPC
  source: MESH
  identifier: C470482
- word: ceramide
  source: MESH
  identifier: D002518
- word: LPA
  source: MESH
  identifier: C522988
- word: sphingosine
  source: MESH
  identifier: D013110
diseases:
- word: CIP
  source: MESH
  identifier: D010259
- word: tumor
  source: MESH
  identifier: D009369
---
